Xinyuan Real Estate (XIN)

[surfer44]

Xinyuan Announces Strategic Cooperation with Wanda Group
March 30 2022 - 09:27AM
PR Newswire (US)

BEIJING, March 30, 2022 /PRNewswire/ -- Xinyuan Real Estate Co., Ltd. ("Xinyuan" or "the Company") (NYSE: XIN), an NYSE-listed real estate developer operating primarily in China with assets in other countries, today announced that the Company and Wanda Group held a strategic cooperation conference in Beijing on March 28, 2022. Mr. Jianlin Wang, Chairman of Wanda Group, and Mr. Yong Zhang, Chairman of Xinyuan Real Estate, were in attendance. During the conference, Xinyuan and Wanda Group signed a strategic cooperation agreement (the "Agreement"). Pursuant to the Agreement, the parties will establish comprehensive and in-depth business cooperation in business and asset management, industrial real estate, and research and development.

Mr. Yong Zhang, Chairman of Xinyuan Group, said: "We are excited to cooperate with Wanda Group to explore new opportunities in the real estate and business and asset management verticals. Wanda Commercial Properties is the world's largest commercial real estate company. We are confident that this partnership will enable us to leverage our respective strengths and benefit the business of both sides and facilitate our future growth."

About Xinyuan Real Estate Co., Ltd.

Xinyuan Real Estate Co., Ltd. ("Xinyuan") is an NYSE-listed real estate developer and property manager primarily in China with assets in other countries. In China, Xinyuan develops and manages large scale, high quality real estate projects in over ten tier one and tier two cities, including Beijing, Shanghai, Tianjin, Zhengzhou, Jinan, Qingdao, Chengdu, Xi'an, Suzhou, Dalian, Zhuhai and Foshan. Xinyuan was one of the first Chinese real estate developers to enter the U.S. market and over the past few years has been active in real estate development in New York. Xinyuan aims to provide comfortable and convenient real estate related products and services to middle-class consumers. For more information, please visit http://www.xyre.com.